...
首页> 外文期刊>Biological & pharmaceutical bulletin >Development, Characterization and Potential Applications of a Multicellular Spheroidal Human Blood-Brain Barrier Model Integrating Three Conditionally Immortalized Cell Lines
【24h】

Development, Characterization and Potential Applications of a Multicellular Spheroidal Human Blood-Brain Barrier Model Integrating Three Conditionally Immortalized Cell Lines

机译:多细胞球形人血脑屏障模型整合三种条件永生化细胞系的开发,表征和潜在应用

获取原文
获取原文并翻译 | 示例

摘要

In vitro blood-brain barrier (BBB) models are essential research tools for use in developing brain-targeted drugs and understanding the physiological and pathophysiological functions of the BBB. To develop BBB models with better functionalities, three-dimensional (3D) culture methods have gained significant attention as a promising approach. In this study, we report on the development of a human conditionally immortalized cell-based multicellular spheroidal BBB (hiMCS-BBB) model. After being seeded into non-attachment culture wells, HASTR/ci35 (astrocytes) and HBPC/ci37 cells (brain pericytes) self-assemble to form a spheroid core that is then covered with an outer monolayer of HBMEC/cil8 cells (brain microvascular endothelial cells). The results of immunocytochemistry showed the protein expression of several cellular junction and BBB-enriched transporter genes in HBMEC/cil8 cells of the spheroid model. The permeability assays showed that the hiMCS-BBB model exhibited barrier functions against the penetration of dextran (5 and 70kDa) and rhodamine123 (a P-glycoprotein substrate) into the core. On the other hand, facilitation of 2-(N-[7-nitrobenz-2-oxa-1,3-diazol-1-yl]amino)-2-deoxyglucose (2-NBDG; a fluorescent glucose analog) uptake was observed in the hiMCS-BBB model. Furthermore, tumor necrosis factor-alpha treatment elicited an inflammatory response in HBMEC/ci18 cells, thereby suggesting that BBB inflammation can be recapitulated in the hiMCS-BBB model. To summarize, we have developed an hiMCS-BBB model that possesses fundamental BBB properties, which can be expected to provide a useful and highly accessible experimental platform for accelerating various BBB studies.
机译:体外血脑屏障(BBB)模型是用于开发脑靶向药物的基本研究工具,了解BBB的生理和病理生理功能。为了开发具有更好函数的BBB模型,三维(3D)培养方法已作为有希望的方法获得重大关注。在这项研究中,我们报告了人有条件不变的细胞基多细胞球形BBB(HIMCS-BBB)模型的发展。在将非附着培养孔中播种后,碱气/ CI35(星形胶质细胞)和HBPC / CI37细胞(脑周细胞)自组装以形成球芯,然后用HBMEC / CIL8细胞的外层覆盖(脑微血管内皮细胞)。免疫细胞化学的结果表明,在球体模型的HBMEC / CIL8细胞中含有几种细胞结和BBB富集的转运基因的蛋白质表达。渗透性测定结果表明,HIMCS-BBB模型将屏障功能表现出抗葡聚糖(5和70KDA)和罗丹明123(P-糖蛋白基材)进入核心的屏障功能。另一方面,观察到促进2-(N- [7-硝基苯-2-氧气-1,3-二唑-1-基]氨基)-2-脱氧葡萄糖(2-NBDG;荧光葡萄糖类似物)摄取在HIMCS-BBB模型中。此外,肿瘤坏死因子-α治疗引发了HBMEC / CI18细胞中的炎症反应,从而可以在HIMCS-BBB模型中概括BBB炎症。为了总结,我们开发了一个拥有基本BBB属性的HIMCS-BBB模型,可以预期为加速各种BBB研究提供有用和高度可接近的实验平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号